CONGRESS ABSTRACT

Introduction Mechanical valve (MV) dysfunction may result from thrombosis, pannus ingrowth, structural degeneration or infective endocarditis. Accurate identification of the underlying etiology is essential, as management differs substantially between thrombotic and non-thrombotic causes. The 2025 ESC guidelines on valvular heart disease emphasize multimodality imaging and Heart Team discussion for…

Background: Patients undergoing surgical aortic valve replacement (SAVR) for severe aortic stenosis (AS) remain at considerable long-term risk for adverse cardiovascular events. Traditional surgical risk scores often fail to capture functional and subclinical predictors of late complications. Methods: We retrospectively analysed 101 consecutive patients who underwent isolated SAVR for…

A 58-year-old man was diagnosed in his 30s with mitral valve prolapse due to myxomatous degeneration. His family history was notable for ischemic heart disease (his father died suddenly from myocardial infarction) and hypertrophic cardiomyopathy (HCM). The patient is heterozygous for a likely pathogenic variant in the troponin I…

Background: The possible influence of chest wall conformation on cardiovascular (CV) outcome of patients with mitral regurgitation (MR) due to mitral valve prolapse (MVP) has never been previously investigated. Methods: This retrospective study included all consecutive symptomatic patients with MVP and moderate MR who underwent exercise stress echocardiography at…

Infective endocarditis (IE) is an infection of the endocardium caused by bacteria or, less frequently, fungi, with an incidence of 3–10 cases per 100,000 people/year. Prosthetic valve endocarditis accounts for 20–30% of cases. Fungal IE is rare (2–4%) but severe, with mortality exceeding 50%. Candida species are most common,…